Articles
- The approval process for hyperthermic intraoperative intraperitoneal chemotherapy
- Peritoneal Surface Oncology: A progress report
- Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites
- Systemic chemotherapy in the management of malignant peritoneal mesothelioma
- Quantitative prognostic indicators of peritoneal dissemination of gastric cancer
- The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms
- Management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy
- Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan
- Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies
- Phase II studies: International registry of colorectal carcinomatosis
- Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer
- Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination
- Neoadjuvant treatment of gastric cancer with peritoneal dissemination
- Quantitative prognostic indices in peritoneal carcinomatosis
- Laparoscopic staging of peritoneal surface malignancies
- Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion
- A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy
- Establishment of a peritoneal malignancy treatment centre in the United Kingdom
- Comprehensive management of diffuse malignant peritoneal mesothelioma